These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Incremental value of extracellular volume assessment by cardiovascular magnetic resonance imaging in risk stratifying patients with suspected myocarditis. Gräni C; Bière L; Eichhorn C; Kaneko K; Agarwal V; Aghayev A; Steigner M; Blankstein R; Jerosch-Herold M; Kwong RY Int J Cardiovasc Imaging; 2019 Jun; 35(6):1067-1078. PubMed ID: 30756221 [TBL] [Abstract][Full Text] [Related]
5. Contrast-enhanced T1 mapping-based extracellular volume fraction independently predicts clinical outcome in patients with non-ischemic dilated cardiomyopathy: a prospective cohort study. Youn JC; Hong YJ; Lee HJ; Han K; Shim CY; Hong GR; Suh YJ; Hur J; Kim YJ; Choi BW; Kang SM Eur Radiol; 2017 Sep; 27(9):3924-3933. PubMed ID: 28439651 [TBL] [Abstract][Full Text] [Related]
6. Combination of extracellular volume fraction by cardiac magnetic resonance imaging and QRS duration for the risk stratification for patients with non-ischemic dilated cardiomyopathy. Kodama S; Kato S; Hayakawa K; Azuma M; Kagimoto M; Iguchi K; Fukuoka M; Fukui K; Iwasawa T; Utsunomiya D; Kosuge M; Kimura K; Tamura K Heart Vessels; 2020 Oct; 35(10):1439-1445. PubMed ID: 32417957 [TBL] [Abstract][Full Text] [Related]
7. Native T1 Mapping and Extracellular Volume Mapping for the Assessment of Diffuse Myocardial Fibrosis in Dilated Cardiomyopathy. Nakamori S; Dohi K; Ishida M; Goto Y; Imanaka-Yoshida K; Omori T; Goto I; Kumagai N; Fujimoto N; Ichikawa Y; Kitagawa K; Yamada N; Sakuma H; Ito M JACC Cardiovasc Imaging; 2018 Jan; 11(1):48-59. PubMed ID: 28624408 [TBL] [Abstract][Full Text] [Related]
8. Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects. Hong YJ; Park CH; Kim YJ; Hur J; Lee HJ; Hong SR; Suh YJ; Greiser A; Paek MY; Choi BW; Kim TH Int J Cardiovasc Imaging; 2015 Jun; 31 Suppl 1():115-22. PubMed ID: 25634119 [TBL] [Abstract][Full Text] [Related]
10. Extracellular volume fraction by T1 mapping predicts improvement of left ventricular ejection fraction after catheter ablation in patients with non-ischemic dilated cardiomyopathy and atrial fibrillation. Azuma M; Kato S; Sekii R; Kodama S; Kinoshita K; Suzurikawa K; Kagimoto M; Nakayama N; Iguchi K; Fukui K; Iwasawa T; Utsunomiya D; Kimura K; Tamura K Int J Cardiovasc Imaging; 2021 Aug; 37(8):2535-2543. PubMed ID: 33725266 [TBL] [Abstract][Full Text] [Related]
11. T1 Mapping and Extracellular Volume Fraction in Dilated Cardiomyopathy: A Prognosis Study. Li S; Zhou D; Sirajuddin A; He J; Xu J; Zhuang B; Huang J; Yin G; Fan X; Wu W; Sun X; Zhao S; Arai AE; Lu M JACC Cardiovasc Imaging; 2022 Apr; 15(4):578-590. PubMed ID: 34538631 [TBL] [Abstract][Full Text] [Related]
12. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis. Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704 [TBL] [Abstract][Full Text] [Related]
13. Extracellular volume fraction assessed using cardiovascular magnetic resonance can predict improvement in left ventricular ejection fraction in patients with dilated cardiomyopathy. Inui K; Asai K; Tachi M; Yoshinaga A; Izumi Y; Kubota Y; Murai K; Tsukada YT; Amano Y; Kumita S; Shimizu W Heart Vessels; 2018 Oct; 33(10):1195-1203. PubMed ID: 29560528 [TBL] [Abstract][Full Text] [Related]
14. Extracellular Volume Associates With Outcomes More Strongly Than Native or Post-Contrast Myocardial T1. Treibel TA; Fridman Y; Bering P; Sayeed A; Maanja M; Frojdh F; Niklasson L; Olausson E; Wong TC; Kellman P; Miller CA; Moon JC; Ugander M; Schelbert EB JACC Cardiovasc Imaging; 2020 Jan; 13(1 Pt 1):44-54. PubMed ID: 31103587 [TBL] [Abstract][Full Text] [Related]
15. Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients. Behera DR; V K AK; K K NN; S S; Nair KKM; G S; T R K; Gopalakrishnan A; S H Indian Heart J; 2020; 72(5):362-368. PubMed ID: 33189195 [TBL] [Abstract][Full Text] [Related]
16. Early detection of myocardial fibrosis in cardiomyopathy in the absence of late enhancement: role of T1 mapping and extracellular volume analysis. Gao Y; Wang HP; Liu MX; Gu H; Yuan XS; Biekan J; Wang XM Eur Radiol; 2023 Mar; 33(3):1982-1991. PubMed ID: 36241919 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of myocardial strain and late gadolinium enhancement on cardiovascular magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy with moderate to severely reduced ejection fraction. Pi SH; Kim SM; Choi JO; Kim EK; Chang SA; Choe YH; Lee SC; Jeon ES J Cardiovasc Magn Reson; 2018 Jun; 20(1):36. PubMed ID: 29898740 [TBL] [Abstract][Full Text] [Related]
18. Native T1 heterogeneity for predicting reverse remodeling in patients with non-ischemic dilated cardiomyopathy. Kinoshita M; Kato S; Kodama S; Azuma M; Nakayama N; Fukui K; Saito N; Iwasawa T; Kimura K; Tamura K; Utsunomiya D Heart Vessels; 2022 Sep; 37(9):1541-1550. PubMed ID: 35320392 [TBL] [Abstract][Full Text] [Related]
19. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly. Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686 [TBL] [Abstract][Full Text] [Related]
20. A novel cardiac magnetic resonance-based personalized risk stratification model in dilated cardiomyopathy: a prospective study. Zhou D; Zhu L; Wu W; Zhuang B; He J; Xu J; Yang W; Wang Y; Li S; Sun X; Sharma P; Liu G; Sirajuddin A; Arai A; Zhao S; Lu M Eur Radiol; 2024 Jun; 34(6):4053-4064. PubMed ID: 37950081 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]